StemCell Therapy

CHARLOTTESVILLE, Va., Aug. 10, 2017 /PRNewswire/ -- Biovista announced today that it is collaborating with HPE to advance Biovista's Project Prodigy Big Data AI healthcare platform applied in the personalized medicine vertical. Advances from the HPE-Biovista collaboration will be used initially within the context of Biovista's existing collaboration with Sarah Bush Lincoln Health Center (SBL), a hospital and health care organization that is home to more than 300,000 provider office visits per year.

HPE is joining the ongoing effort between Biovista and SBL and will work with Biovista to help advance the capabilities and productization of Project Prodigy as a Big Data AI engine in the personalized medicine vertical as a start.

Biovista develops advanced technologies that use Big Data and next generation analytics to address major needs in data-heavy verticals, with healthcare and personalized medicine as an initial focus. HPE and Biovista's new collaboration will leverage HPE computing and Biovista's Big Data AI engine, Project Prodigy, to identify and validate new therapeutic options for personalized medicine, starting with the community hospital setting.

"It's exciting to see Project Prodigy help advance the practice of healthcare," Aris Persidis, Ph.D. Biovista's president said. "The aim is to help doctors deliver more targeted care with fewer side effects in a way that integrates well with their workflow and is also cost effective. We are happy to be working with HPE within the context of our work at SBL to accelerate the advances of Project Prodigy in personalized medicine."

"Medicine as currently practiced in the United States is hardly sustainable financially," noted James Hildebrandt, MD, VP Medical Affairs at SBL . "We need to deliver better care with fewer side effects at a lower cost, or the system will fail. Efforts like the SBL-Biovista-HPE collaboration in personalized medicine that aim to combine IT efficiencies with sound medical practice promise to move us in the right direction."

"Project Prodigy offers unique prospects to apply AI Deep Learning techniques and Big Data analytics to personalized medicine," said Dr. Stephen Wheat, Director, HPC Vertical Solutions and Apollo Pursuits. "Combining HPE capabilities with Project Prodigy is a powerful and exciting path forward for us in personalized medicine, as well as in other verticals that have emerging AI Deep Learning workflows."

James Hildebrandt further noted, "We are very happy to work with Biovista to advance the practice of personalized medicine using the very best technologies available. SBL continually works to incorporate leading edge capabilities, including those at the forefront of big data healthcare analytics, such as Biovista's Project Prodigy, as we deliver high quality care close to home for our patients and communities. We see the Biovista-HPE link within the context of our SBL-Biovista collaboration as very positive for SBL and our patient community."

About Biovista: Biovista develops advanced technologies that use big data and next generation analytics to address major needs in biomedical R&D and clinical practice. Project Prodigy is a new category of inference generation and validation system. Biovista is using Project Prodigy to advance its own drug repositioning programs, as well as in programs with biopharmaceutical companies, regulators, and patient advocacy groups.

About SBL: Sarah Bush Lincoln provides a full range of acute care services to residents of East Central Illinois' Coles County and the surrounding eight counties. Primary care services are provided through 14 extended campus primary care locations and three walk-in clinics. Post Acute Care services extend to the surrounding 19 counties in East Central and Southern Illinois through active and consulting medical staffs that include approximately 175 providers representing 28 specialties delivered throughout the health center, including its 129 bed hospital, its cancer center, heart center and other centers of excellence.

Employing about 2,300 area residents, the health center promotes a culture of excellence through continuing personal and professional growth. SBL has received the Illinois Performance Excellence Gold Award for Achievement of Excellence in 2011, and is accredited by The Joint Commission, the nation's oldest and largest standards-setting and accrediting body in healthcare.

View original content:http://www.prnewswire.com/news-releases/biovista-expands-project-prodigy-collaborations-in-personalized-medicine-300502425.html

SOURCE Biovista

Read this article:
Biovista expands Project Prodigy collaborations in personalized medicine - Markets Insider

This entry was posted on August 14, 2017 at 2:41 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |